Adverse effects of antipsychotics and quality of life;Efectos adversos de los antipsicóticos y calidad de vida

Actas Espanolas de Psiquiatria

Volumn 33, Issue 1, 2005, Pages 1-6

  Minguez Martin L ^a   Gonzalez Pablos E ^a   Alonso Del Teso, F ^a   Sanguino Andres R M ^a   Garcia Alonso Y ^a  

^a Reanimación y Terapéutica del Dolor   (Spain)

Author keywords

Adverse effects; Antipsychotics; Neuroleptics; Quality of life; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; AUTONOMIC DYSFUNCTION; CONTROLLED STUDY; DISEASE COURSE; EXTRAPYRAMIDAL SYNDROME; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC DISEASE; QUALITY OF LIFE; SCHIZOPHRENIA; SEX ROLE; SIDE EFFECT; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SCHIZOPHRENIA;

EID: 16244410769     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Bech P. Problems in measurement quality of life in schizophrenia. Nort Psykiatr Tidsskr 1990;44:77-9.
2. Bobes J, González MP, Fernández JM, Bascarán MT, Saiz PA, Martínez S, et al. Calidad de vida relacionada con el tratamiento antipsicótico. Actas Esp Psiquiatr 2001;29(1):46-50.
3. Skantze K, Malm U, Dencker SJ, May PHR. Quality of life in schizophrenia. Nord Psykiatr 1990;44:71-5.
4. Lehman AF. The well-being of chronic mental patients. Assessing their quality of life. Arch Gen Psychiatry 1983;40:369-73.
5. Lehman AF, Postrado LT, Rachuba LT. Convergent validation of quality of life assessments for persons with severe mental illnesses. Quality Life Res 1993;2:327-33.
6. Browne S, Roe M, Lane A, Gervin M, Morris M, Kinsella A, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive diskinesia. Acta Psychiatr Scand 1996;94:118-24.
7. Sainfort F, Becker M, Diamond R. Judgments of quality of life of individuals with severe mental disorders: patient self-report versus provider perspectives. Am J Psychiatry 1996;153:497-502.
8. Heinrichs DW, Hanlon ET, Carpenter WT. The quality of life scale: an instrument for rating the schizophrenic deficit syndrome. Schiz Bull 1984;10:388-98.
9. Lehman AF. A quality of life interview for the chronically mentally III (QOLI). Eval Prog Planning 1988;11:51-62.
10. Bobes J, González MP, Bousoño M. Calidad de vida en psiquiatria. En: Barcia D, editor. Tratado de Psiquiatria. Madrid: Arán Editores, 2000;831-43.
11. Giner J, Ibáńez E, Baca E, Bobes J, Leal C, Cervera S. Desarrollo del Cuestionario Sevilla de Calidad de Vida (CSCV). Actas Luso Esp Neurol Psiquiatr Cienc Afines 1997;25(2):11-23.
12. Bow-Thomas CC, Velligan DI, Miller AL, Olsen J. Predicting quality of life from symptomatology in schizophrenia at exacerbation and stabilization. Psychiatry Res 1999;86:131-42.
13. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC. Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998;155:1196-201.
14. Tollefson GD, Andersen SW. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life. J Clin Psychiatry 1999;60(5):23-9.
15. Herrán A, Sierra-Biddle D, Cuesta MJ, Sandoya M, Diez-Manrique JF, Vázquez-Barquero JL. Determinantes de la calidad de vida en pacientes con esquizofrenia crónica. I Congreso Virtual de Psiquiatría, 2001.
16. Kemmler G, Holzner B, Neudorfer Ch, Schwitzer J, Meise U. What constitutes overall life satisfaction of chronic schizophrenic outpatients? Results of a pilot study using the lancashire quality of life profile. Quality Life Res 1995;4:445-6.
17. Browne S Roe M, Lane A, Gervin M, Morris M, Kinsella A, Larkin C, et al. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomathology and tardive diskinesia. Acta Psychiatr Scand 1996;94:118-24.
18. Morcillo L, Barcia D, Borgonós E. Esquizofrenia: calidad de vida y años de evolución. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1995;23:293-8.
19. Sullivan G, Wells KB, Leake B. Clinical factors associated with better quality of life in a seriously mentally III population. Hosp Commun Psych 1992;43:794-8.
20. Barcia D, Morcillo L, Borgonós E. Esquizofrenia, calidad de vida y formas clinicas. An Psiquiatría 1995;11(3):81-7.
21. Baker F, Intagliata J. Quality of life in the evaluation of community support systems. Eval Program Planning 1982;5:69-79.
22. Simpson CJ, Hyde CE, Faragher EB. The chronically mentally Ill in community facilities. A study of quality of life. Br J Psychiatry 1989;154:77-82.
23. Mercier C, Renaud C, Desbiens F, Gervais S. The contribution of services to the quality of life of psychiatric patients in the community. Otawa: Health and Welfare Canada, 1990.
24. Mercier C, King S. A latent variable causal model of the quality of life and community tenure of psychotic patients. Acta Psychiatr Scand 1994;89:72-7.
25. Bigelow DA, McFarland BH, Olson MM. Quality of life of community mental health programs clients: validating a measure. Community Mental Health J 1991;27:43-55.
26. Lehman AF, Possidente S, Hawker F. The quality of life of chronic patients in a state hospital and in community residences. Hosp Commun Psych 1986;37(9):901-7.
27. Lehman AF, Slaughter JG, Myers CP. Quality of life in alternative residential settings. Psychiatric Quarterly 1991;62:35-49.
28. Cohi A. Estudio comparativo de la calidad de vda en pacientes esquizofrénicos según la condición de tratamiento. Rev Psiquiatria Fac Med Barna 1990;17(5):201-18.
29. Barcia D, Ayuso JL, Herraiz ML. Calidad de vida en pacientes esquizofrénicos tratados con risperidona. An Psiquiatria 1996;12(10):403-12.
30. Bobes J, Gutiérrez M, Gilbert J. Calidad de vida y discapacidad en pacientes esquizofrénicos crónicos en tratamiento con risperidona y previamente tratados con neurolépticos depot. Actas Esp Psiquiatr 1999;27(4):229-34.
31. Franz M, Lis S, Pluddemann K, Gallhofer B. Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients. Br J Psychiatry 1997;170:422-5.
32. Rosenheck RA, Cramer J, Xu W, Thomas J, Henderson W, et al. Department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. A comparison of clozapine and haloperidol in the treatment of hospitalized patients with refractory schizophrenia. N Engl J Med 1997;337:809-15.
33. Revicki DA, Haley J, Hamilton S, Genduso L, Beasley C. Quality of life outcomes for olanzapine and haloperidol treatment for schizophrenia and other psychotic disorders: results on an international randomized clinical trial. Presentación en la 4th Annual Conference of the International Society for Quality of Life Research. Viena, 1997.
34. Hamilton SH, Revicki DA, Genduso LA, Beasley CM. Olanzapine versus placebo and haloperidol: quality of life and efficacy results of the North American double-blind trial. Neuropsychopharmacol 1998;18:41-9.
35. Voruganti LNP, Heslegrave RJ, Awad AG. Quality of life measurement during antipsychotic drug therapy of schizophrenia. J Psychiatry Neurosci 1997;22:267-74.